Involvement of mitogen-activated protein kinases in the signal transduction pathway of bone marrow-derived macrophage activation in response to in vitro treatment with thymosin alpha 1

International Immunopharmacology

Volumn 2, Issue 1, 2002, Pages 47-58

  Sodhi, Ajit ^a   Paul, Saki ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Bone marrow derived macrophages; MAP kinase; Signal transduction; Thymosin alpha 1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NITRIC OXIDE; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; THYMOSIN ALPHA1; TUMOR NECROSIS FACTOR ALPHA; WORTMANNIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DOSE TIME EFFECT RELATION; ENZYME ACTIVATION; FEMALE; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VITRO STUDY; MACROPHAGE ACTIVATION; MALE; MEDIATOR RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL SEPARATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ENZYME INHIBITORS; GTP-BINDING PROTEINS; INDICATORS AND REAGENTS; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NITRATES; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; THYMOSIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035192088     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(01)00139-4     Document Type: Article

References (59)

1. Molecular mechanisms of signal transduction in macrophages
2. Macrophage cytotoxicity: Role for L-arginine deiminase and imino-nitrogen oxidation to nitrite
3. Release of cytolytic factor(s) by murine peritoneal macrophages in vitro on treatment with cisplatin
4. Nitric oxide: A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells
5. Cellular models of macrophage tumoricidal effector mechanisms in vitro: Characterization of cytolytic responses to tumor necrosis factor and NO pathways in vitro
6. Cytolytic mechanisms(s) of activated macrophages: Tumor necrosis factor and L-arginine dependent mechanisms act synergistically as the major cytolytic mechanisms of activated macrophages
7. Tumor necrosis factor: A potent effector molecule for tumor-cell killing by activated macrophages
8. Production of tumor necrosis factor and interleukin 1 by cisplatin-treated murine peritoneal macrophages
9. The chemistry and biology of thymosin: I. Isolation and characterization and biological activities of thymosin alpha 1 and polypeptide beta 1 from calf thymus
10. Thymosin α 1: Chemistry, mechanism of action and clinical applications
11. Thymic peptide hormones: Basic properties and clinical applications in cancer
12. In vitro induction of lyt surface markers on precursor cells incubated with thymosin polypeptide
13. Modulation of terminal deoxynucleotidyl transferase activity by thymosin
14. Modulation of human natural killer cell cytotoxicity activity, lymphokine production and interleukin 2 receptor expression by thymic hormones
15. Modulation of natural killer activity by Tα1 and interferon
16. Tα1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes
17. Synergistic effect of thymosin α 1 and α, β-interferon on NK activity in tumor-bearing mice
18. Combination treatment using thymosin α 1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice
19. Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in treatment of Lewis lung carcinoma in mice
20. High doses of thymosin alpha 1 enhance the anti-tumor efficacy of combination chemo-immunotherapy for murine B16 melanoma
21. Comprehensive compilation of clinical studies with thymic peptides in oncology: An update
22. Clinical applications of thymosin alpha-1
23. Oncogenes and signal transduction
24. The MAPK signaling cascade
25. Mitogen-activated protein kinase pathways
26. The mitogen-activated protein kinase signal transduction pathway
27. Involvement of Ras and MAPkinase (ERK-1) in cisplatin-induced activation of murine bone marrow-derived macrophages
28. Bacterial lipopolysaccharide induces phosphorylation and activation of mitogen-activated protein kinase in macrophages
29. Interleukin-8 regulation of the ras/Raf/mitogen-activated protein kinase pathway in human neutrophils
30. Protein kinase cascades activated by stress and inflammatory cytokines
31. Requirement for integration of signals from two district phosphorylation pathways for the activation of MAP kinase
32. Activation of murine bone-marrow derived macrophages in vitro with thymosin-alpha-1 to tumoricidal state: A comparative study on normal and tumor-bearing hosts
33. Augmentation of cytotoxin from murine bone marrow macrophages by γ-interferon
34. Production of IL-1 and TNF by bone marrow-derived macrophages: Effect of cisplatin and LPS
35. In vitro activation of bone marrow derived macrophages with cisplatin and mitomycin C
36. Purification and properties of T-cell derived colony stimulating factor
37. Induction of tumoricidal macrophages from bone-marrow cells of normal mice bearing a colony-stimulating factor producing tumor
38. 2 intermediates from murine peritoneal macrophages: Comparison of activating cytokines and evidence for independent production
39. Cytotoxicity assay for tumor necrosis factor and lymphotoxin
40. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo
41. Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation
42. Phosphorylation of c-Jun mediated by MAP kinase
43. Oncoprotein mediated signaling cascade stimulates c-Jun activity by phosphorylation of serine 63 and 73
44. JNK 1: A protein kinase stimulated by UV light and Ita-Ras that binds and phosphorylates the c-Jun activation domain
45. Preclinical studies on thymosin α1 and thymosin β4
46. Chemotactic peptides induce phosphorylation and activation of MEK-1 in human neutrophils
47. FMLP activates Ras and Raf in human neutrophils: Potential role in activation of MAP kinase
48. Direct stimulation of tyrosine phosphorylation of microtubule associated protein (MAP) kinase activity by granulocyte macrophage colony stimulating factor in human neutrophil
49. Activation of mitogen-activated protein kinases regulates eotaxin-induced eosinophil migration
50. MIP-3α induces human eosinophil migration and activation of the mitogen-activated protein kinases (p42/44 MAPK)
51. Receptors for thymosin α 1 on mouse thymocytes
52. Regulation of tyrosine kinase cascades by G-protein-coupled receptors
53. Early signal transduction by the receptor to the chemokine monocyte chemoattractant protein-1 in a murine T-cell hybrid
54. Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling
55. The coordinated actions of protein tyrosine phosphatases and kinases in cell signaling
56. Regulation of immune functions by protein tyrosine phosphatases
57. Mechanism of NF-kB translocation in macrophages treated in vitro with cisplatin
58. Role of transcription factor NF-kB/Rel in induction of nitric oxide synthase
59. NF-kB: A pleiotropic mediator of inducible and tissue specific gene control